Cargando…

Development and Evaluation of an Integrated Digital Patient Platform During Oncology Treatment

BACKGROUND: Patient platforms are seen as promising technologies in an integrated care approach to involve cancer patients in their own health care and to support them in managing their personal health information. However, few digital platforms have been codesigned with patients and caregivers. OBJ...

Descripción completa

Detalles Bibliográficos
Autores principales: De Regge, Melissa, Decoene, Elsie, Eeckloo, Kristof, Van Hecke, Ann
Formato: Online Artículo Texto
Lenguaje:English
Publicado: SAGE Publications 2019
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7036686/
https://www.ncbi.nlm.nih.gov/pubmed/32128372
http://dx.doi.org/10.1177/2374373518825142
_version_ 1783500256403521536
author De Regge, Melissa
Decoene, Elsie
Eeckloo, Kristof
Van Hecke, Ann
author_facet De Regge, Melissa
Decoene, Elsie
Eeckloo, Kristof
Van Hecke, Ann
author_sort De Regge, Melissa
collection PubMed
description BACKGROUND: Patient platforms are seen as promising technologies in an integrated care approach to involve cancer patients in their own health care and to support them in managing their personal health information. However, few digital platforms have been codesigned with patients and caregivers. OBJECTIVE: To develop, implement, and evaluate the feasibility and applicability of a digital oncology platform (DOP) for patients with cancer. METHOD: A mixed-method study was used, employing a survey, interviews, and logged data from caregivers and patients. The DOP was designed in cooperation with Information Technology (IT) staff, caregivers, and patients. RESULTS: The DOP was actively used by half of the patients. These active patients were positive about the DOP. Caregivers acknowledged the added value but also indicate that additional workload was involved. Oncology nurse specialists are the users of the platform. General practitioners have indicated their interest in the platform. CONCLUSION: Thanks to the codesign process, the DOP could be tailored to the expectations of the end users. This study provides insight into which DOP functionalities the patients were interested in and includes further recommendations for implementation.
format Online
Article
Text
id pubmed-7036686
institution National Center for Biotechnology Information
language English
publishDate 2019
publisher SAGE Publications
record_format MEDLINE/PubMed
spelling pubmed-70366862020-03-03 Development and Evaluation of an Integrated Digital Patient Platform During Oncology Treatment De Regge, Melissa Decoene, Elsie Eeckloo, Kristof Van Hecke, Ann J Patient Exp Research Articles BACKGROUND: Patient platforms are seen as promising technologies in an integrated care approach to involve cancer patients in their own health care and to support them in managing their personal health information. However, few digital platforms have been codesigned with patients and caregivers. OBJECTIVE: To develop, implement, and evaluate the feasibility and applicability of a digital oncology platform (DOP) for patients with cancer. METHOD: A mixed-method study was used, employing a survey, interviews, and logged data from caregivers and patients. The DOP was designed in cooperation with Information Technology (IT) staff, caregivers, and patients. RESULTS: The DOP was actively used by half of the patients. These active patients were positive about the DOP. Caregivers acknowledged the added value but also indicate that additional workload was involved. Oncology nurse specialists are the users of the platform. General practitioners have indicated their interest in the platform. CONCLUSION: Thanks to the codesign process, the DOP could be tailored to the expectations of the end users. This study provides insight into which DOP functionalities the patients were interested in and includes further recommendations for implementation. SAGE Publications 2019-01-21 2020-02 /pmc/articles/PMC7036686/ /pubmed/32128372 http://dx.doi.org/10.1177/2374373518825142 Text en © The Author(s) 2019 https://creativecommons.org/licenses/by-nc/4.0/ This article is distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 License (https://creativecommons.org/licenses/by-nc/4.0/) which permits non-commercial use, reproduction and distribution of the work without further permission provided the original work is attributed as specified on the SAGE and Open Access pages (https://us.sagepub.com/en-us/nam/open-access-at-sage).
spellingShingle Research Articles
De Regge, Melissa
Decoene, Elsie
Eeckloo, Kristof
Van Hecke, Ann
Development and Evaluation of an Integrated Digital Patient Platform During Oncology Treatment
title Development and Evaluation of an Integrated Digital Patient Platform During Oncology Treatment
title_full Development and Evaluation of an Integrated Digital Patient Platform During Oncology Treatment
title_fullStr Development and Evaluation of an Integrated Digital Patient Platform During Oncology Treatment
title_full_unstemmed Development and Evaluation of an Integrated Digital Patient Platform During Oncology Treatment
title_short Development and Evaluation of an Integrated Digital Patient Platform During Oncology Treatment
title_sort development and evaluation of an integrated digital patient platform during oncology treatment
topic Research Articles
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7036686/
https://www.ncbi.nlm.nih.gov/pubmed/32128372
http://dx.doi.org/10.1177/2374373518825142
work_keys_str_mv AT dereggemelissa developmentandevaluationofanintegrateddigitalpatientplatformduringoncologytreatment
AT decoeneelsie developmentandevaluationofanintegrateddigitalpatientplatformduringoncologytreatment
AT eecklookristof developmentandevaluationofanintegrateddigitalpatientplatformduringoncologytreatment
AT vanheckeann developmentandevaluationofanintegrateddigitalpatientplatformduringoncologytreatment